PAIS Solution for Life Sciences

Pharmaceutical, emerging biotech and medical device companies experience three phases of growth: discovery, development and clinical and commercialisation – and each step demands specific technology needs. The discovery phase typically requires a six- to 10-application ecosystem with cost considerations being paramount. The development and clinical phase calls for applications with a more expansive infrastructure, and efficiency is key. The commercialisation phase adds further complexity, with ongoing regulatory requirements, as sales, marketing and other functions focus on growth. It’s a complicated process under the best of circumstances.